SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-21-067981
Filing Date
2021-12-30
Accepted
2021-12-29 18:26:16
Documents
2
Group Members
CASDIN CAPITAL, LLCCASDIN PARTNERS GP, LLCCASDIN PARTNERS MASTER FUND, L.P.CASDIN PRIVATE GROWTH EQUITY FUND GP, LLCCASDIN VENTURES OPPORTUNITIES FUNDS, L.P.CMLS HOLDINGS III LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea153190-13dcasdin_eqrxinc.htm SC 13D 203081
2 JOINT FILING AGREEMENT ea153190ex99-1_eqrxinc.htm EX-99.1 20870
  Complete submission text file 0001213900-21-067981.txt   225511
Mailing Address 1350 AVENUE OF THE AMERICAS SUITE 1140 NEW YORK NY 10019
Business Address
Casdin Eli (Filed by) CIK: 0001534264 (see all company filings)

Type: SC 13D

Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 6173152266
EQRx, Inc. (Subject) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93138 | Film No.: 211530161
SIC: 2834 Pharmaceutical Preparations